Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? (Q71681814)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

A Salmaggi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Dufour

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Eoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

E Corsini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

L La Mantia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

G Massa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Nespolo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C Milanese

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

13-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00878525

20 October 2019

exact match

0 references

cites work

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

1 reference

12 December 2020

TGF-beta-like activity produced during regression of exacerbations in multiple sclerosis

1 reference

12 December 2020

Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases

1 reference

12 December 2020

Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production

1 reference

12 December 2020

Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis

1 reference

12 December 2020

Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

1 reference

12 December 2020

Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI

1 reference

12 December 2020

High levels of "complexed" interleukin-6 in human blood

1 reference

12 December 2020

Progressive multiple sclerosis: abnormal immune functions in vitro and aberrant correlation with enumeration of lymphocyte subpopulations

1 reference

12 December 2020

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis

1 reference

12 December 2020

Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis

1 reference

12 December 2020

Diagnosis and classification of multiple sclerosis

1 reference

12 December 2020

Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery

1 reference

12 December 2020

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

12 December 2020

High levels of circulating IL-10 in human malaria

1 reference

12 December 2020

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

12 December 2020

Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels

1 reference

12 December 2020

IL-10 inhibits cytokine production by activated macrophages

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility

1 reference

12 December 2020

Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system

1 reference

12 December 2020

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody

1 reference

12 December 2020

Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis

1 reference

12 December 2020

Analysis of T regulator cell surface markers and functional properties in multiple sclerosis

1 reference

12 December 2020

Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis

1 reference

12 December 2020

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid

1 reference

12 December 2020

Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.

1 reference

12 December 2020

Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders

1 reference

12 December 2020

Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor

1 reference

12 December 2020

A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum

1 reference

12 December 2020

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00878525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869381%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference